BRPI0519354A2 - mÉtodo para detecÇço de um anticorpo terapÊutico e uso de um anticorpo - Google Patents

mÉtodo para detecÇço de um anticorpo terapÊutico e uso de um anticorpo

Info

Publication number
BRPI0519354A2
BRPI0519354A2 BRPI0519354-0A BRPI0519354A BRPI0519354A2 BR PI0519354 A2 BRPI0519354 A2 BR PI0519354A2 BR PI0519354 A BRPI0519354 A BR PI0519354A BR PI0519354 A2 BRPI0519354 A2 BR PI0519354A2
Authority
BR
Brazil
Prior art keywords
antibody
therapeutic
sample
therapeutic antibody
detecting
Prior art date
Application number
BRPI0519354-0A
Other languages
English (en)
Inventor
Helmut Lenz
Kay-Gunnar Stubenrauch
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34927934&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0519354(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0519354A2 publication Critical patent/BRPI0519354A2/pt
Publication of BRPI0519354B1 publication Critical patent/BRPI0519354B1/pt
Publication of BRPI0519354B8 publication Critical patent/BRPI0519354B8/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

MÉTODO PARA DETECÇçO DE UM ANTICORPO TERAPÊUTICO E USO DE UM ANTICORPO. A presente invenção refere-se ao campo dos anticorpos terapêuticos. Refere-se especialmente ao estudo dos anticorpos terapêuticos em um animal experimental. A presente invenção descreve um método para a detecção de um anticorpo terapêutico em uma amostra obtida a partir de um animal experimental compreendendo as etapas de (a) provendo a amostra a ser analisada, (b) incubando a referida amostra com um anticorpo que se liga a um anticorpo terapêutico e não se liga a imunoglobulina do referido animal experimental, (c) opcionalmente incubando a referida amostra com um reagente apropriado para a detecção seletiva do anticorpo terapêutico total, ativo ou ligado ao antígeno, e (d) correlacionando o complexo formado em (b) ou (c) com a concentração do referido anticorpo terapêutico.
BRPI0519354A 2004-12-23 2005-12-22 método para detecção de um anticorpo terapêutico e uso de um anticorpo BRPI0519354B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04030545 2004-12-23
PCT/EP2005/013849 WO2006066912A2 (en) 2004-12-23 2005-12-22 Detection of a therapeutic antibody in an experimental animal

Publications (3)

Publication Number Publication Date
BRPI0519354A2 true BRPI0519354A2 (pt) 2009-01-20
BRPI0519354B1 BRPI0519354B1 (pt) 2020-06-09
BRPI0519354B8 BRPI0519354B8 (pt) 2021-07-27

Family

ID=34927934

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0519354A BRPI0519354B8 (pt) 2004-12-23 2005-12-22 método para detecção de um anticorpo terapêutico e uso de um anticorpo

Country Status (15)

Country Link
US (1) US7955806B2 (pt)
EP (2) EP1853921B2 (pt)
JP (2) JP4664377B2 (pt)
KR (1) KR100950635B1 (pt)
CN (1) CN101088014B (pt)
AT (1) ATE503187T1 (pt)
AU (2) AU2005318407B2 (pt)
BR (1) BRPI0519354B8 (pt)
CA (1) CA2589054C (pt)
DE (1) DE602005027127D1 (pt)
ES (1) ES2360369T5 (pt)
MX (1) MX2007006895A (pt)
RU (1) RU2393483C2 (pt)
SG (1) SG164389A1 (pt)
WO (1) WO2006066912A2 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101506659B (zh) * 2006-09-12 2012-12-12 弗·哈夫曼-拉罗切有限公司 抗药物抗体测定法
EP2067044B1 (en) 2006-09-12 2013-07-03 F. Hoffmann-La Roche AG Anti-drug antibody assay
JP5634405B2 (ja) * 2008-10-07 2014-12-03 ユィロス・パテント・アクチボラグGyros Patent AB 試料中のアナライトの検出のための半逐次アッセイ
EP2356148A2 (en) 2008-11-10 2011-08-17 Novartis AG Antibodies to modified human igf-1/e peptides
CN105624118B (zh) 2009-10-19 2019-08-13 弗·哈夫曼-拉罗切有限公司 非交叉反应性抗IgG抗体
WO2012022682A1 (en) 2010-08-17 2012-02-23 F. Hoffmann-La Roche Ag Anti-human igg1 antibody
CN104136923B (zh) 2012-03-08 2016-08-24 霍夫曼-拉罗奇有限公司 用于表征循环免疫复合物的多重层析-免疫测定方法
CA2878814C (en) 2012-08-17 2023-03-14 Morphosys Ag Complex-specific antibodies and antibody fragments and its use
EP2986990B1 (en) 2013-03-20 2018-08-15 F.Hoffmann-La Roche Ag Specific detection of rat antibodies in mouse serum
EP3375875B1 (en) 2015-11-09 2026-04-15 National University Corporation Kyoto Institute of Technology Separating agent for human serum-derived igg polyclonal antibodies, and method for separating human serum-derived igg polyclonal antibodies using same
CN107703310B (zh) * 2017-10-11 2019-08-30 潍坊医学院附属医院 一种针对老鼠免疫抗体的实验操作系统
EP4085251B1 (en) * 2020-01-02 2024-07-31 F. Hoffmann-La Roche AG Method for determining the amount of a therapeutic antibody in the brain

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2095818B (en) 1981-03-27 1985-10-02 Exxon Research Engineering Co Staged adsorption/resorption heat pump
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4870003A (en) * 1987-06-15 1989-09-26 Coulter Corporation Simultaneous enzyme immunoassay for detecting antigen and/or antibody in humans
US4816067A (en) * 1988-06-20 1989-03-28 Gte Products Corporation Process for producing fine spherical particles
ATE255131T1 (de) 1991-06-14 2003-12-15 Genentech Inc Humanisierter heregulin antikörper
WO1993021319A1 (en) 1992-04-08 1993-10-28 Cetus Oncology Corporation HUMANIZED C-erbB-2 SPECIFIC ANTIBODIES
US5736137A (en) * 1992-11-13 1998-04-07 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
EP0938334A4 (en) 1996-07-26 2004-12-15 Smithkline Beecham Corp IMPROVED METHOD FOR TREATING IMMUNE-MEDIATED SYSTEMIC DISEASES
US6525174B1 (en) * 1997-06-06 2003-02-25 Human Genome Sciences, Inc. Precerebellin-like protein
US6413783B1 (en) * 1997-09-18 2002-07-02 Meso Scale Technologies, Llc Assay sonication apparatus and methodology
JP2000304750A (ja) * 1999-04-16 2000-11-02 Fuji Photo Film Co Ltd 発光標識イムノアッセイ及びその分析要素
IT1315254B1 (it) 1999-11-05 2003-02-03 Diesse Diagnostica Senese Spa Metodo per la determinazione qualitativa e quantitativa di anticorpiumani di classe igc.
AUPR617901A0 (en) 2001-07-06 2001-08-02 Pacmab Pty Ltd Method for treating multiple myeloma
ATE443259T1 (de) 2001-09-20 2009-10-15 Univ Texas Bestimmung der zirkulierenden therapeutischen antikörper, antigene sowie antigen-antikörper- komplexe mit elisa-tests
JP4636225B2 (ja) 2002-11-30 2011-02-23 司甫 横山 検査試薬キット

Also Published As

Publication number Publication date
US7955806B2 (en) 2011-06-07
JP4664377B2 (ja) 2011-04-06
RU2007128103A (ru) 2009-01-27
EP1853921A2 (en) 2007-11-14
CN101088014A (zh) 2007-12-12
JP2008525766A (ja) 2008-07-17
AU2005318407A1 (en) 2006-06-29
US20080102474A1 (en) 2008-05-01
KR100950635B1 (ko) 2010-04-01
EP1853921B1 (en) 2011-03-23
RU2393483C2 (ru) 2010-06-27
WO2006066912A3 (en) 2006-08-10
JP2011039072A (ja) 2011-02-24
CN101088014B (zh) 2012-10-03
MX2007006895A (es) 2007-06-26
SG164389A1 (en) 2010-09-29
DE602005027127D1 (de) 2011-05-05
CA2589054A1 (en) 2006-06-29
AU2010200299A1 (en) 2010-02-18
KR20070086642A (ko) 2007-08-27
EP1853921B2 (en) 2021-07-21
ATE503187T1 (de) 2011-04-15
AU2005318407B2 (en) 2009-11-05
WO2006066912A2 (en) 2006-06-29
EP2237041A1 (en) 2010-10-06
BRPI0519354B1 (pt) 2020-06-09
ES2360369T5 (es) 2021-12-13
CA2589054C (en) 2010-11-02
ES2360369T3 (es) 2011-06-03
WO2006066912A9 (en) 2007-02-22
BRPI0519354B8 (pt) 2021-07-27

Similar Documents

Publication Publication Date Title
NO20076662L (no) Deteksjon av et malantigen uavhengig av tilstedevaerelse eller fravaer av et korresponderende terapeutisk antistoff
ATE425266T1 (de) Aptamer-nanopartikelkonjugate und verwendungsverfahren zur detektion von zielanalyten
WO2008051762A3 (en) Immunoassay of analytes in samples containing endogenous anti-analyte antibodies
WO2006126008A3 (en) Improved immunoassay methods
WO2006089027A3 (en) Lateral flow test kit and method for detecting an analyte
ATE423972T1 (de) Vorrichtung und verfahren um gleichzeitig verschiedene antikörper und antigene nachzuweisen in klinischen, nahrungsmittel- und umwelt-proben
ATE538715T1 (de) System zur in vivo analyse
BRPI0519354B8 (pt) método para detecção de um anticorpo terapêutico e uso de um anticorpo
MX369610B (es) Metodos, dispositivos y sistemas para analisis de muestras.
ATE466108T1 (de) Optoelektronisches detektionssystem
WO2005103698A3 (en) Methods and antibodies for nitrofuran detection
EP3736571A4 (en) METHOD, REAGENT AND CHIP FOR MEASURING THE ANALYTE CONCENTRATION IN A BIOLOGICAL SAMPLE
DE60333876D1 (de) Methoden zum Nachweis Analyten in Proben
ATE405837T1 (de) Festphase immunochromatographische testverfahren
WO2007024735A3 (en) Method and antibodies for detecting nitrofuran
WO2007063326A3 (en) Assay device and method
WO2008067007A3 (en) A method for quantitative measurement of thyroid homrones and related antibodies in a serum sample
WO2006071970A3 (en) Methods for the detection of analytes in a sample
WO2007076013A3 (en) Homocysteine immunoassay
ATE533053T1 (de) Nicht-elispot-test
ATE520985T1 (de) Verfahren zur bestimmung von antigen und antikörper gegen das antigen
WO2012141792A3 (en) Adiponectin receptor c-terminal fragments (ctf)-immunoglobulin
WO2006098849A3 (en) Method and device for detecting feline immunodeficiency virus
DE69920981D1 (de) Knorpelresorptionsassays
ATE505730T1 (de) Verfahren zum nachweis einer an einen nukleären rezeptor gebundenen substanz

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06H Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette]

Free format text: REF. A RPI NO 2150 DE 20/03/2012. ANULACAO DA EXIGENCIA 6.6 POR TER SIDO INDEVIDA. REQUERENTE NAO APRESENTOU RESPOSTA A EXIGENCIA CONFORME DISPOE A RESOLUCAO 207 DE 24/04/2009, ENTRETANTO, A RESPOSTA CONSTA NO FORMULARIO DE DEPOSITO.

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 09/06/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 22/12/2005, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO